Expertise in
20
conditions

Julia V. Mayerle

Munich, BY, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
20
conditions
Munich, BY, DE 

Overview

Julia Mayerle practices practicing medicine in Munich, Germany.

Ms. Mayerle is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Hereditary Pancreatitis, Chronic Pancreatitis, Acute Pancreatitis, Gallbladder Removal, and Lithotripsy.

She is actively involved in clinical research, co-authoring 351 peer reviewed articles and participating in 4 clinical trials.

Gender

Female

Locations

Munich, BY, Germany
Other Locations
Erlangen, BY, Germany
Bayern, BY, Germany
Heidelberg, BW 69120, Germany
Mecklenburg, MV, Germany
Greifswald, MV 17475, Germany
Tuebingen, BW, Germany
Ernst, RP, Germany
Giessen, HE, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, 2-arm Non-comparative Phase II Study on the Efficacy of Atezolizumab and Roche Bevacizumab (Atezo/Bev) Followed by On-demand Selective TACE (sdTACE) Upon Detection of Disease Progression or of Initial Synchronous Treatment With TACE and Atezo/Bev on 24-months Survival Rate in the Treatment of Unresectable Hepatocellular Carcinoma Patients
A Randomized, 2-arm Non-comparative Phase II Study on the Efficacy of Atezolizumab and Roche Bevacizumab (Atezo/Bev) Followed by On-demand Selective TACE (sdTACE) Upon Detection of Disease Progression or of Initial Synchronous Treatment With TACE and Atezo/Bev on 24-months Survival Rate in the Treatment of Unresectable Hepatocellular Carcinoma Patients
Enrollment Status: Recruiting
Publish Date: June 14, 2024
Intervention Type: Combination product
Study Drug: Atezolizumab Injection, Bevacizumab Injection
Study Phase: Phase 2
Double Blind Randomised Controlled Trial to Investigate the Efficacy of ANTOX (Vers) 1.2 and MGCT (Magnesiocard) for the Treatment of Hereditary Pancreatitis and Idiopathic Chronic Pancreatitis
Double Blind Randomised Controlled Trial to Investigate the Efficacy of ANTOX (Vers) 1.2 and MGCT (Magnesiocard) for the Treatment of Hereditary Pancreatitis and Idiopathic Chronic Pancreatitis
Enrollment Status: Completed
Publish Date: March 27, 2020
Intervention Type: Other, Dietary supplement, Drug
Study Phase: Phase 3
Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE-
Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE-
Enrollment Status: Completed
Publish Date: September 20, 2019
Intervention Type: Dietary supplement
Study Phase: Phase 2
TRICC-C: A Multicenter, Randomized, Phase II Trial: BIBF 1120 vs. Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC)
TRICC-C: A Multicenter, Randomized, Phase II Trial: BIBF 1120 vs. Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC)
Enrollment Status: Completed
Publish Date: September 19, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

351 Total Publications

Rituximab limits glucocorticoid use in IgG4-related disease: Real-world evidence from a large European cohort.
Rituximab limits glucocorticoid use in IgG4-related disease: Real-world evidence from a large European cohort.
Journal: European journal of internal medicine
Published: December 15, 2025

Frequently Asked Questions about Julia V. Mayerle

Is Julia V. Mayerle a top-rated expert for Hereditary Pancreatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Julia V. Mayerle is classified as an Elite expert for Hereditary Pancreatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Julia V. Mayerle participate in research or clinical trials?

Yes. Julia V. Mayerle has published 351 articles and abstracts on conditions like Hereditary Pancreatitis. You can view a list of Julia V. Mayerle's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Mayerle's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 46 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile